Skip to search boxSkip to navigationSkip to main content

Interleukin 33/ST2 axis components are associated to desmoplasia, a metastasis-related factor in colorectal cancer

  • Glauben Landskron
    ,
  • Marjorie De la Fuente López
    ,
  • Karen Dubois-Camacho
    ,
  • David Díaz-Jiménez
    ,
  • Octavio Orellana-Serradell
    ,
  • Diego Romero
*Corresponding author for this work
  • Universidad de Chile
    ,
  • Clínica Las Condes
    ,
  • Laboratory of Innate Immunity
    ,
  • Pontificia Universidad Católica de Chile
    ,
  • Pathology Department
    ,
  • Inflammatory Bowel Diseases Program
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Article number

1394

Journal (Volume, Issue Number)

Frontiers in Immunology (Volume 10, Issue JUN)

Publication milestones

  • Published - 01/01/2019

Publication status

Published - 01/01/2019

Publication IDs

  • Scopus: 85069195214
  • PubMed: 31281317

Abstract

In colorectal cancer (CRC), cancer-associated fibroblasts (CAFs) are the most abundant component from the tumor microenvironment (TM). CAFs facilitate tumor progression by inducing angiogenesis, immune suppression and invasion, thus altering the organization/composition of the extracellular matrix (i.e., desmoplasia) and/or activating epithelial-mesenchymal transition (EMT). Soluble factors from the TM can also contribute to cell invasion through secretion of cytokines and recently, IL-33/ST2 pathway has gained huge interest as a protumor alarmin, promoting progression to metastasis by inducing changes in TM. Hence, we analyzed IL-33 and ST2 content in tumor and healthy tissue lysates and plasma from CRC patients. Tissue localization and distribution of these molecules was evaluated by immunohistochemistry (using localization reference markers α-smooth muscle actin or α-SMA and E-cadherin), and clinical/histopathological information was obtained from CRC patients. In vitro experiments were conducted in primary cultures of CAFs and normal fibroblasts (NFs) isolated from tumor and healthy tissue taken from CRC patients. Additionally, migration and proliferation analysis were performed in HT29 and HCT116 cell lines. It was found that IL-33 content increases in left-sided CRC patients with lymphatic metastasis, with localization in tumor epithelia associated with abundant desmoplasia. Although ST2 content showed similarities between tumor and healthy tissue, a decreased immunoreactivity was observed in left-sided tumor stroma, associated to metastasis related factors (advanced stages, abundant desmoplasia, and presence of tumor budding). A principal component analysis (including stromal and epithelial IL-33/ST2 and α-SMA immunoreactivity with extent of desmoplasia) allowed us to distinguish clusters of low, intermediate and abundant desmoplasia, with potential to develop a diagnostic signature with benefits for further therapeutic targets. IL-33 transcript levels from CAFs directly correlated with CRC cell line migration induced by CAFs conditioned media, with rhIL-33 inducing a mesenchymal phenotype in HT29 cells. These results indicate a role of IL-33/ST2 in tumor microenvironment, specifically in the interaction between CAFs and epithelial tumor cells, thus contributing to invasion and metastasis in left-sided CRC, most likely by activating desmoplasia.

Publication metrics

Metrics

SciVal
FWCI
0.63
Scopus
citations

PlumX, opens in new tab

Citation count
24
Captures
51